P
MRK icon

&Partners’s Merck MRK Stock Holding History

&Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.3M Buy
562,388
+55,794
+11% +$6.53M 0.3% 65
2026
Q1 		$61M Buy
506,594
+2,694
+0.5% +$311K 0.3% 68
2025
Q4 		$53M Buy
503,900
+33,464
+7% +$3.14M 0.28% 76
2025
Q3 		$39.5M Buy
470,436
+22,358
+5% +$1.84M 0.25% 83
2025
Q2 		$35.5M Sell
448,078
-53,701
-11% -$4.27M 0.27% 81
2025
Q1 		$44.8M Buy
501,779
+80,574
+19% +$7.52M 0.48% 46
2024
Q4 		$41.8M Buy
421,205
+183,288
+77% +$18.9M 0.5% 42
2024
Q3 		$27.1M Buy
237,917
+146,691
+161% +$17.4M 0.52% 38
2024
Q2 		$11.3M Buy
91,226
+62,947
+223% +$8.11M 0.49% 44
2024
Q1 		$3.76M Buy
28,279
+9,452
+50% +$1.17M 0.52% 37
2023
Q4 		$2.1M Buy
18,827
+9,995
+113% +$1.04M 0.51% 50
2023
Q3 		$909K Buy
8,832
+286
+3% +$30.8K 0.42% 46
2023
Q2 		$986K Sell
8,546
-86
-1% -$9.77K 0.44% 44
2023
Q1 		$918K Sell
8,632
-749
-8% -$80.9K 0.44% 46
2022
Q4 		$1.04M Sell
9,381
-1,668
-15% -$170K 0.52% 42
2022
Q3 		$952K Sell
11,049
-250
-2% -$22.3K 0.55% 42
2022
Q2 		$1.03M Buy
11,299
+1,485
+15% +$132K 0.59% 35
2022
Q1 		$805K Buy
9,814
+5,571
+131% +$439K 0.45% 52
2021
Q4 		$325K Buy
4,243
+250
+6% +$19.9K 0.2% 116
2021
Q3 		$300K Hold
3,993
– – 0.19% 121
2021
Q2 		$311K Buy
3,993
+752
+23% +$55.9K 0.2% 116
2021
Q1 		$238K Hold
3,241
– – 0.17% 130
2020
Q4 		$253K Buy
3,241
+248
+8% +$19K 0.21% 105
2020
Q3 		$245K Buy
+2,993
New +$234K 0.25% 96

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

&Partners's MRK Position: Q2 2026 in Review

&Partners increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $6.53M and bringing the position to 562,388 shares worth $72.3M. The position accounts for 0.3% of the portfolio, ranked #65.

&Partners first reported a position in MRK in Q3 2020 and has held it in 24 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • &Partners held 562,388 shares of Merck worth $72.3M as of Q2 2026.
  • &Partners bought 55,794 Merck shares in Q2 2026, an estimated $6.53M.
  • Merck made up 0.3% of &Partners's portfolio in Q2 2026, its #65 holding.
  • &Partners first reported a position in Merck in Q3 2020 and has held it in 24 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.